INVELTYS Drug Patent Profile
✉ Email this page to a colleague
When do Inveltys patents expire, and what generic alternatives are available?
Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are ten patents protecting this drug.
This drug has seventy-eight patent family members in twelve countries.
The generic ingredient in INVELTYS is loteprednol etabonate. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Inveltys
A generic version of INVELTYS was approved as loteprednol etabonate by AKORN on April 17th, 2019.
Summary for INVELTYS
International Patents: | 78 |
US Patents: | 10 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Patent Applications: | 5,254 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for INVELTYS |
What excipients (inactive ingredients) are in INVELTYS? | INVELTYS excipients list |
DailyMed Link: | INVELTYS at DailyMed |


Anatomical Therapeutic Chemical (ATC) Classes for INVELTYS
US Patents and Regulatory Information for INVELTYS
INVELTYS is protected by eleven US patents.
Patents protecting INVELTYS
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD FOR DELIVERING A PHARMACEUTICAL AGENT ACROSS A MUCOSAL BARRIER
Compositions and methods for ophthalmic and/or other applications
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Compositions and methods for ophthalmic and/or other applications
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Compositions and methods for ophthalmic and/or other applications
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD FOR TREATING OCULAR INFLAMMATION
Compositions and methods for ophthalmic and/or other applications
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD OF REDUCING POST-SURGICAL PAIN FOLLOWING OCULAR SURGERY
Compositions and methods for ophthalmic and/or other applications
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD OF TREATING POSTOPERATIVE INFLAMMATION FOLLOWING OCULAR SURGERY
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD FOR DELIVERING A COMPOSITION TO A MUCUS MEMBRANE
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD FOR DELIVERING A COMPOSITION TO A MUCUS MEMBRANE
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD FOR DELIVERING A PHARMACEUTICAL AGENT ACROSS A MUCOSAL BARRIER
Compositions and methods for ophthalmic and/or other applications
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD FOR TREATING INFLAMMATION AND/OR OTHER DISORDERS IN AN EYE OF A PATIENT
International Patents for INVELTYS
See the table below for patents covering INVELTYS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2844295 | NANOPARTICULES PHARMACEUTIQUES PERMETTANT UN TRANSPORT MUQUEUX AMÉLIORÉ (PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT) | See Plans and Pricing |
Brazil | 112014027296 | nanopartículas farmacêuticas mostrando transporte mucosal melhorado | See Plans and Pricing |
China | 105916509 | 用于眼科应用和/或其它应用的组合物以及方法 (Compositions and methods for ophthalmic and/or other applications) | See Plans and Pricing |
Canada | 2871748 | NANOPARTICULES PHARMACEUTIQUES A TRANSPORT MUCOSAL AMELIORE (PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT) | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2013166408 | See Plans and Pricing | |
Japan | 6816065 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |